Innokenty A. Savin

620 total citations · 1 hit paper
25 papers, 374 citations indexed

About

Innokenty A. Savin is a scholar working on Molecular Biology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Innokenty A. Savin has authored 25 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Immunology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Innokenty A. Savin's work include RNA Interference and Gene Delivery (11 papers), MicroRNA in disease regulation (5 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Innokenty A. Savin is often cited by papers focused on RNA Interference and Gene Delivery (11 papers), MicroRNA in disease regulation (5 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Innokenty A. Savin collaborates with scholars based in Russia, Germany and United Kingdom. Innokenty A. Savin's co-authors include Aleksandra V. Sen’kova, Marina A. Zenkova, Andrey V. Markov, Valentin V. Vlassov, Elena V. Shmendel, М. А. Маслов, С. К. Мирошниченко, Dmitry A. Stetsenko, Olga Patutina and Н. Л. Миронова and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Innokenty A. Savin

24 papers receiving 368 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pulmonary Fibrosis as a Result of Acute Lung Inflammation: Molecular Mechanisms, Relevant In Vivo Models, Prognostic and Therapeutic Approaches

2022 154 citations Innokenty A. Savin, Marina A. Zenkova et al. International Journal of Molecular Sciences profile →

Peers

Countries citing papers authored by Innokenty A. Savin

Since Specialization

Citations

This map shows the geographic impact of Innokenty A. Savin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Innokenty A. Savin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Innokenty A. Savin more than expected).

Fields of papers citing papers by Innokenty A. Savin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Innokenty A. Savin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Innokenty A. Savin. The network helps show where Innokenty A. Savin may publish in the future.

Co-authorship network of co-authors of Innokenty A. Savin

This figure shows the co-authorship network connecting the top 25 collaborators of Innokenty A. Savin. A scholar is included among the top collaborators of Innokenty A. Savin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Innokenty A. Savin. Innokenty A. Savin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pulmozyme Ameliorates LPS-Induced Lung Fibrosis but Provokes Residual Inflammation by Modulating Cell-Free DNA Composition and Controlling Neutrophil Phenotype 2025 ·Biomolecules ·(unknown), Aleksandra V. Sen’kova, (unknown), Innokenty A. Savin, Marina A. Zenkova, Н. Л. Миронова	1
2	Tumor- and Fibroblast-Derived Cell-Free DNAs Differently Affect the Progression of B16 Melanoma In Vitro and In Vivo 2024 ·International Journal of Molecular Sciences ·(unknown), (unknown), Aleksandra V. Sen’kova, Innokenty A. Savin, (unknown), Marina A. Zenkova, Н. Л. Миронова	3
3	Tbp and Hprt1 Are Appropriate Reference Genes for Splenic Neutrophils Isolated from Healthy or Tumor-Bearing Mice 2024 ·Biomedicines ·(unknown), (unknown), Aleksandra V. Sen’kova, Innokenty A. Savin, Marina A. Zenkova, Н. Л. Миронова	1
4	Cholesterol-Modified Anti-Il6 siRNA Reduces the Severity of Acute Lung Injury in Mice 2024 ·Cells ·Ivan V. Chernikov, (unknown), Aleksandra V. Sen’kova, Mariya I. Meschaninova, Innokenty A. Savin, Valentin V. Vlassov, Marina A. Zenkova, Elena L. Chernolovskaya	3
5	The Effect of Cell-Free DNA from Blood Serum of Mice with Metastatic Melanoma on Enhancement of Oncogenic Properties of Melanoma Cells 2023 ·Biochemistry (Moscow) ·(unknown), (unknown), Innokenty A. Savin, Aleksandra V. Sen’kova, Marina A. Zenkova, Н. Л. Миронова	2
6	Identification of Novel Core Genes Involved in Malignant Transformation of Inflamed Colon Tissue Using a Computational Biology Approach and Verification in Murine Models 2023 ·International Journal of Molecular Sciences ·Andrey V. Markov, Innokenty A. Savin, Marina A. Zenkova, Aleksandra V. Sen’kova	5
7	Cholesterol-Conjugated Supramolecular Multimeric siRNAs: Effect of siRNA Length on Accumulation and Silencing In Vitro and In Vivo 2023 ·Nucleic Acid Therapeutics ·Ivan V. Chernikov, (unknown), Mariya I. Meschaninova, (unknown), (unknown), (unknown), Innokenty A. Savin, Valentin V. Vlassov, Marina A. Zenkova, Elena L. Chernolovskaya	3
8	siRNA-Mediated Timp1 Silencing Inhibited the Inflammatory Phenotype during Acute Lung Injury 2023 ·International Journal of Molecular Sciences ·Ivan V. Chernikov, (unknown), (unknown), Aleksandra V. Sen’kova, Innokenty A. Savin, Andrey V. Markov, (unknown), Elena L. Chernolovskaya, Marina A. Zenkova, Valentin V. Vlassov	9
9	Influence of the Composition of Cationic Liposomes on the Performance of Cargo Immunostimulatory RNA 2023 ·Pharmaceutics ·(unknown), (unknown), Elena V. Shmendel, М. А. Маслов, Aleksandra V. Sen’kova, Innokenty A. Savin, (unknown), Marina A. Zenkova, Elena L. Chernolovskaya	9
10	Bronchial Asthma, Airway Remodeling and Lung Fibrosis as Successive Steps of One Process 2023 ·International Journal of Molecular Sciences ·Innokenty A. Savin, Marina A. Zenkova, Aleksandra V. Sen’kova	52
11	Novel Epoxides of Soloxolone Methyl: An Effect of the Formation of Oxirane Ring and Stereoisomerism on Cytotoxic Profile, Anti-Metastatic and Anti-Inflammatory Activities In Vitro and In Vivo 2022 ·International Journal of Molecular Sciences ·Oksana V. Salomatina, Aleksandra V. Sen’kova, (unknown), Innokenty A. Savin, Н. И. Комарова, Нариман Ф. Салахутдинов, Marina A. Zenkova, Andrey V. Markov	10
12	Single Shot vs. Cocktail: A Comparison of Mono- and Combinative Application of miRNA-Targeted Mesyl Oligonucleotides for Efficient Antitumor Therapy 2022 ·Cancers ·С. К. Мирошниченко, Olga Patutina, Aleksandra V. Sen’kova, Е. А. Буракова, Innokenty A. Savin, Andrey V. Markov, Elena V. Shmendel, М. А. Маслов, Dmitry A. Stetsenko, Valentin V. Vlassov, Marina A. Zenkova	14
13	Bovine Pancreatic RNase A: An Insight into the Mechanism of Antitumor Activity In Vitro and In Vivo 2022 ·Pharmaceutics ·(unknown), Aleksandra V. Sen’kova, Oleg V. Markov, Andrey V. Markov, Innokenty A. Savin, Marina A. Zenkova, Н. Л. Миронова	1
14	Asthma and Post-Asthmatic Fibrosis: A Search for New Promising Molecular Markers of Transition from Acute Inflammation to Pulmonary Fibrosis 2022 ·Biomedicines ·Innokenty A. Savin, Andrey V. Markov, Marina A. Zenkova, Aleksandra V. Sen’kova	12
15	Pulmonary Fibrosis as a Result of Acute Lung Inflammation: Molecular Mechanisms, Relevant In Vivo Models, Prognostic and Therapeutic Approaches breakdown → 2022 ·International Journal of Molecular Sciences ·Innokenty A. Savin, Marina A. Zenkova, Aleksandra V. Sen’kova	154
16	Human Recombinant DNase I (Pulmozyme®) Inhibits Lung Metastases in Murine Metastatic B16 Melanoma Model That Correlates with Restoration of the DNase Activity and the Decrease SINE/LINE and c-Myc Fragments in Blood Cell-Free DNA 2021 ·International Journal of Molecular Sciences ·(unknown), Aleksandra V. Sen’kova, Innokenty A. Savin, Marina A. Zenkova, Н. Л. Миронова	11
17	Core genes involved in the regulation of acute lung injury and their association with COVID-19 and tumor progression: A bioinformatics and experimental study 2021 ·PLoS ONE ·Aleksandra V. Sen’kova, Innokenty A. Savin, (unknown), Marina A. Zenkova, Andrey V. Markov	10
18	Mesyl phosphoramidate backbone modified antisense oligonucleotides targeting miR-21 with enhanced in vivo therapeutic potency 2020 ·Proceedings of the National Academy of Sciences ·Olga Patutina, С. К. Мирошниченко, Aleksandra V. Sen’kova, Innokenty A. Savin, (unknown), (unknown), А. А. Фокина, М. А. Маслов, Elena V. Shmendel, (unknown), Valentin V. Vlassov, Sidney Altman, Dmitry A. Stetsenko, Marina A. Zenkova	52
19	Immunostimulating RNA Delivered by P1500 PEGylated Cationic Liposomes Limits Influenza Infection in C57Bl/6 Mice 2020 ·Pharmaceutics ·(unknown), Aleksandra V. Sen’kova, Innokenty A. Savin, Т. О. Кабилова, Marina A. Zenkova, Valentin V. Vlassov, Elena L. Chernolovskaya	6
20	Antitumour Activity of the Ribonuclease Binase from Bacillus pumilus in the RLS40 Tumour Model Is Associated with the Reorganisation of the miRNA Network and Reversion of Cancer-Related Cascades to Normal Functioning 2020 ·Biomolecules ·(unknown), Aleksandra V. Sen’kova, (unknown), Innokenty A. Savin, Andrey V. Markov, Vladimir A. Mitkevich, (unknown), О. N. Ilinskaya, Н. Л. Миронова, Marina A. Zenkova	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact